MedPath
NMPA Approval

benzoylmetronidazole for Suspension

国药准字H20143286

August 12, 2024

Drug Information

苯酰甲硝唑干混悬剂

慧文

口服混悬剂

1g:苯酰甲硝唑0.64g

化学药品

August 12, 2024

Company Information

Applicant Company

北辰科技园区华实道88号

Manufacturing Company

北辰科技园区华实道88号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

苯酰甲硝唑干混悬剂 - NMPA 批准文号 | MedPath